These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14236987)

  • 1. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
    SHIRAI T
    Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
    [No Abstract]   [Full Text] [Related]  

  • 2. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
    BLIX S
    Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
    [No Abstract]   [Full Text] [Related]  

  • 3. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 5. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 6. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 8. FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS.
    MACKAY M
    Br Med Bull; 1964 Sep; 20():189-94. PubMed ID: 14209757
    [No Abstract]   [Full Text] [Related]  

  • 9. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 10. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 11. THE STREPTOKINASE ACTIVATION OF HUMAN PLASMINOGEN. DIRECT ANALYSIS OF THE ACTIVATION MIXTURE.
    RIFE U; SHULMAN S
    Thromb Diath Haemorrh; 1963 Nov; 10():133-45. PubMed ID: 14081275
    [No Abstract]   [Full Text] [Related]  

  • 12. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR.
    GUTMAN M; RIMON A
    Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241
    [No Abstract]   [Full Text] [Related]  

  • 14. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
    [No Abstract]   [Full Text] [Related]  

  • 15. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
    JACOBSEN CD
    Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
    [No Abstract]   [Full Text] [Related]  

  • 16. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 17. USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY.
    RITZ ND; RUBIN H
    J Lab Clin Med; 1964 Feb; 63():344-54. PubMed ID: 14125123
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY].
    KAPPERT A
    Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260
    [No Abstract]   [Full Text] [Related]  

  • 19. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.